This review provides a comprehensive overview of nicotine metabolism; a summary of the use of biomarkers to define smoking dose; and an overview of molecular epidemiology studies of CYP2A6 genotype, nicotine metabolism, and the risk of lung cancer across different racial/ethnic groups. The gene discussed is CYP2A6; the disease is lung carcinoma.